p53-Adjusted Neoadjuvant Chemotherapy for Potentially Resectable Esophageal Cancer (PANCHO)

This study has been completed.
Sponsor:
Collaborators:
Medical University of Vienna
Austrian Society Of Surgical Oncology
Information provided by (Responsible Party):
Daniela Kandioler, Medical University of Vienna
ClinicalTrials.gov Identifier:
NCT00525200
First received: September 4, 2007
Last updated: December 20, 2012
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)